-+ 0.00%
-+ 0.00%
-+ 0.00%

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

ASX·06/03/2025 22:27:35

The content of this announcement was automatically generated by machine and is for reference only. The original announcement can be viewed by clicking on the link below.